Cargando…
Molecular chaperones in the acquisition of cancer cell chemoresistance with mutated TP53 and MDM2 up-regulation
Utilizing the TCGA PANCAN12 dataset we discovered that cancer patients with mutations in TP53 tumor suppressor and overexpression of MDM2 oncogene exhibited decreased survival post treatment. Interestingly, in the case of breast cancer patients, this phenomenon correlated with high expression level...
Autores principales: | Tracz-Gaszewska, Zuzanna, Klimczak, Marta, Biecek, Przemyslaw, Herok, Marcin, Kosinski, Marcin, Olszewski, Maciej B., Czerwińska, Patrycja, Wiech, Milena, Wiznerowicz, Maciej, Zylicz, Alicja, Zylicz, Maciej, Wawrzynow, Bartosz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5669876/ https://www.ncbi.nlm.nih.gov/pubmed/29137250 http://dx.doi.org/10.18632/oncotarget.18899 |
Ejemplares similares
-
Molecular Mechanism of Mutant p53 Stabilization: The Role of HSP70 and MDM2
por: Wiech, Milena, et al.
Publicado: (2012) -
Correction: Molecular Mechanism of Mutant p53 Stabilization: The Role of HSP70 and MDM2
por: Wiech, Milena, et al.
Publicado: (2013) -
Chemotherapy of HER2- and MDM2-Enriched Breast Cancer Subtypes Induces Homologous Recombination DNA Repair and Chemoresistance
por: Herok, Marcin, et al.
Publicado: (2021) -
Heat shock proteins create a signature to predict the clinical outcome in breast cancer
por: Klimczak, Marta, et al.
Publicado: (2019) -
Disruption of RING and PHD Domains of TRIM28 Evokes Differentiation in Human iPSCs
por: Mazurek, Sylwia, et al.
Publicado: (2021)